FDA Permits Marketing of Devices to Create Arteriovenous Fistula

TUESDAY, July 3, 2018 -- The U.S. Food and Drug Administration has permitted marketing of two catheter-based devices designed to create an arteriovenous (AV) fistula in patients with chronic kidney disease in need of hemodialysis.
The devices are...

Source: Drugs.com - Pharma News - July 3, 2018 Category: Pharmaceuticals Source Type: news